On the afternoon of September 11th, Lv Xiangyang, Chairman of the Youngy Group, visited Nanjing Regenecore Company and Thoth Institutes to gain a comprehensive understanding of the current development status and future innovative directions of the two organizations. Accompanied by Chief Scientist Xie Wei and General Manager Wang Yang of Regenecore, Lv Xiangyang toured the R&D platform of Regenecore and the scientific research center of Thoth Institutes. Wang Yang provided a detailed introduction to the company's structure, R&D platform, product pipeline, and progress. Chief Scientist Xie Wei elaborated on Thoth Institutes' planning guided by the "Four Orientations" philosophy, its innovative mechanisms, and profound reflections on present and future scenarios.

Lv Xiangyang engaged in insightful conversations with the heads of various departments at Regenecore, acknowledging the innovative spirit and scientific research capabilities demonstrated by both Regenecore and Thoth Institutes. He emphasized that the Group would offer more support and guidance in the future to accelerate the development of projects related to antibody drugs and human health enhancement. It aims to facilitate rapid project transformation through multiple channels and levels, contributing to China's biomedicine industry and benefiting the broad masses of the people.